Reviews

Research progress in the effects of microRNAs on cardiac electrophysiological properties

  • Jing YI ,
  • Hong GAO ,
  • Sisi. PAN
Expand
  • *.Department of Anesthesiology,the Affiliated Hospital of Guizhou Medical University,Guiyang 550004,China

Received date: 2023-12-11

  Online published: 2024-05-15

Abstract

The incidence of perioperative arrhythmias is 4%~20% in noncardiac surgery and 10% ~ 30% in cardiothoracic surgery, with the incidence of perioperative arrhythmias in cardiac surgery patients as high as 90%. Perioperative arrhythmias can prolong hospitalization and increase morbidity and mortality during hospitalization. Studies have shown that aberrantly expressed microRNAs in cardiovascular diseases can participate in cardiac automaticity, excitability and conductivity by regulating ion channels, gap junction proteins, and intracellular Ca2+ handling proteins, thereby regulating cardiac electrophysiological homeostasis and arrhythmias. In this article, we will review the research progress of microRNAs and arrhythmias mainly from the perspective of cardiac electrophysiological imbalance.

Cite this article

Jing YI , Hong GAO , Sisi. PAN . Research progress in the effects of microRNAs on cardiac electrophysiological properties[J]. The Journal of Practical Medicine, 2024 , 40(9) : 1320 -1323 . DOI: 10.3969/j.issn.1006-5725.2024.09.024

References

1 PECHA S, KIRCHHOF P, REISSMANN B. Perioperative Arrhythmias[J]. Dtsch Arztebl Int, 2023,120(33/34): 564-574.
2 THOMPSON A, BALSER J R. Perioperative cardiac arrhythmias[J]. Br J Anaesth, 2004,93(1): 86-94. doi:10.1093/bja/aeh166
3 YANG D, DESCHêNES I, FU J. Multilayer control of cardiac electrophysiology by microRNAs[J]. J Mol Cell Cardiol, 2022,166: 107-115. doi:10.1016/j.yjmcc.2022.02.007
4 SURINA S, FONTANELLA R A, SCISCIOLA L, et al. miR-21 in Human Cardiomyopathies[J]. Front Cardiovasc Med, 2021,8: 767064. doi:10.3389/fcvm.2021.767064
5 ZENG Y, WU N, ZHANG Z, et al. Non-coding RNA and arrhythmias: expression, function, and molecular mechanism[J]. Europace, 2023,25(4):1296-1308. doi:10.1093/europace/euad047
6 VARRó A, TOMEK J, NAGY N, et al. Cardiac transmembrane ion channels and action potentials: cellular physiology and arrhythmogenic behavior[J]. Physiol Rev, 2021,101(3): 1083-1176. doi:10.1152/physrev.00024.2019
7 KANG G, XIE A, LIU H, et al. MIR448 antagomir reduces arrhythmic risk after myocardial infarction by upregulating the cardiac sodium channel[J]. JCI Insight, 2020,5(23):e140759. doi:10.1172/jci.insight.140759
8 PETKOVA M, ATKINSON A J, YANNI J, et al. Identification of Key Small Non-Coding MicroRNAs Controlling Pacemaker Mechanisms in the Human Sinus Node[J]. J Am Heart Assoc, 2020,9(20): e16590. doi:10.1161/jaha.120.016590
9 LIU X, ZHANG Y, DU W, et al. MiR-223-3p as a Novel MicroRNA Regulator of Expression of Voltage-Gated K+ Channel Kv4.2 in Acute Myocardial Infarction[J]. Cell Physiol Biochem, 2016,39(1): 102-114. doi:10.1159/000445609
10 MATKOVICH S J, WANG W, TU Y, et al. MicroRNA-133a protects against myocardial fibrosis and modulates electrical repolarization without affecting hypertrophy in pressure-overloaded adult hearts[J]. Circ Res, 2010,106(1): 166-175. doi:10.1161/circresaha.109.202176
11 LU Y, ZHANG Y, WANG N, et al. MicroRNA-328 contributes to adverse electrical remodeling in atrial fibrillation[J]. Circulation, 2010: 122(23):2378-2387. doi:10.1161/circulationaha.110.958967
12 LING T, WANG X, CHAI Q, et al. Regulation of cardiac CACNB2 by microRNA-499: Potential role in atrial fibrillation[J]. BBA Clin, 2017,7: 78-84. doi:10.1016/j.bbacli.2017.02.002
13 JIA X, ZHENG S, XIE X, et al. MicroRNA-1 accelerates the shortening of atrial effective refractory period by regulating KCNE1 and KCNB2 expression: an atrial tachypacing rabbit model[J]. PLoS One, 2013,8(12): e85639. doi:10.1371/journal.pone.0085639
14 LI N, ZHOU H, TANG Q. miR-133: A Suppressor of Cardiac Remodeling?[J]. Front Pharmacol, 2018,9: 903. doi:10.3389/fphar.2018.00903
15 YANG B, LIN H, XIAO J, et al. The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2[J]. Nat Med, 2007,13(4): 486-491. doi:10.1038/nm1569
16 LUO X, PAN Z, SHAN H, et al. MicroRNA-26 governs profibrillatory inward-rectifier potassium current changes in atrial fibrillation[J]. J Clin Invest, 2013,123(5): 1939-1951. doi:10.1172/jci62185
17 FITZPATRICK C M. MicroRNA directly modulates cardiac ion channel[J]. Nat Rev Cardiol, 2021,18(5): 308. doi:10.1038/s41569-021-00540-5
18 PETKOVA M, ATKINSON A J, YANNI J, et al. Identification of Key Small Non-Coding MicroRNAs Controlling Pacemaker Mechanisms in the Human Sinus Node[J]. J Am Heart Assoc, 2020,9(20): e16590. doi:10.1161/jaha.120.016590
19 YANNI J, D'SOUZA A, WANG Y, et al. Silencing miR-370-3p rescues funny current and sinus node function in heart failure[J]. Sci Rep, 2020,10(1): 11279. doi:10.1038/s41598-020-67790-0
20 LI N, ARTIGA E, KALYANASUNDARAM A, et al. Altered microRNA and mRNA profiles during heart failure in the human sinoatrial node[J]. Sci Rep, 2021,11(1): 19328. doi:10.1038/s41598-021-98580-x
21 TERENTYEV D, BELEVYCH A E, TERENTYEVA R, et al. miR-1 overexpression enhances Ca(2+) release and promotes cardiac arrhythmogenesis by targeting PP2A regulatory subunit B56alpha and causing CaMKII-dependent hyperphosphorylation of RyR2[J]. Circ Res, 2009,104(4): 514-521. doi:10.1161/circresaha.108.181651
22 PARK J, KHO C. MicroRNAs and Calcium Signaling in Heart Disease[J]. Int J Mol Sci, 2021,22(19):10582. doi:10.3390/ijms221910582
23 CHENG W, KAO Y, CHAO T, et al. MicroRNA-133 suppresses ZFHX3-dependent atrial remodelling and arrhythmia[J]. Acta Physiol (Oxf), 2019,227(3): e13322. doi:10.1111/apha.13322
24 HAN B, TREW M L, ZGIERSKI-JOHNSTON C M. Cardiac Conduction Velocity, Remodeling and Arrhythmogenesis[J]. Cells, 2021,10(11):2923. doi:10.3390/cells10112923
25 YI J, DUAN H, CHEN K, et al. Cardiac Electrophysiological Changes and Downregulated Connexin 43 Prompts Reperfusion Arrhythmias Induced by Hypothermic Ischemia-Reperfusion Injury in Isolated Rat Hearts[J]. J Cardiovasc Transl Res, 2022,15(6): 1464-1473. doi:10.1007/s12265-022-10256-7
26 ZHAO Y, RANSOM J F, LI A, et al. Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2[J]. Cell, 2007,129(2): 303-317. doi:10.1016/j.cell.2007.03.030
27 CALLIS T E, PANDYA K, SEOK H Y, et al. MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice[J]. J Clin Invest, 2009,119(9): 2772-2786. doi:10.1172/jci36154
28 WANG J, XU L, TIAN L, et al. Circulating microRNA-208 family as early diagnostic biomarkers for acute myocardial infarction: A meta-analysis[J]. Medicine, 2021,100(51): e27779. doi:10.1097/md.0000000000027779
29 DHEIN S, SALAMEH A. Remodeling of Cardiac Gap Junctional Cell-Cell Coupling[J]. Cells, 2021,10(9):2422. doi:10.3390/cells10092422
30 BILLUR D, OLGAR Y, TURAN B. Intracellular Redistribution of Left Ventricular Connexin 43 Contributes to the Remodeling of Electrical Properties of the Heart in Insulin-resistant Elderly Rats[J]. J Histochem Cytochem, 2022,70(6): 447-462. doi:10.1369/00221554221101661
31 OSBOURNE A, CALWAY T, BROMAN M, et al. Downregulation of connexin43 by microRNA-130a in cardiomyocytes results in cardiac arrhythmias[J]. J Mol Cell Cardiol, 2014,74: 53-63. doi:10.1016/j.yjmcc.2014.04.024
32 WANG N, SUN L, ZHANG S, et al. MicroRNA-23a participates in estrogen deficiency induced gap junction remodeling of rats by targeting GJA1[J]. Int J Biol Sci, 2015,11(4): 390-403. doi:10.7150/ijbs.10930
33 NAPPI F, IERVOLINO A, AVTAAR SINGH S S, et al. MicroRNAs in Valvular Heart Diseases: Biological Regulators, Prognostic Markers and Therapeutical Targets[J]. Int J Mol Sci, 2021,22(22):12132. doi:10.3390/ijms222212132
Outlines

/